| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | XMD13-2 | GDSC1000 | pan-cancer | AAC | 0.063 | 0.06 |
| mRNA | Imatinib | CTRPv2 | pan-cancer | AAC | 0.069 | 0.07 |
| mRNA | AUY922 | GDSC1000 | pan-cancer | AAC | -0.069 | 0.07 |
| mRNA | Panobinostat | CCLE | pan-cancer | AAC | 0.085 | 0.07 |
| mRNA | OSU-03012 | GDSC1000 | pan-cancer | AAC | -0.068 | 0.07 |
| mRNA | AC55649 | CTRPv2 | pan-cancer | AAC | 0.072 | 0.07 |
| mRNA | 17-AAG | GDSC1000 | pan-cancer | AAC | -0.064 | 0.07 |
| mRNA | lenvatinib | CTRPv2 | pan-cancer | AAC | 0.07 | 0.07 |
| mRNA | QS11 | GDSC1000 | pan-cancer | AAC | -0.069 | 0.07 |
| mRNA | Compound 23 citrate | CTRPv2 | pan-cancer | AAC | 0.064 | 0.07 |